Saúde Pública/Medicina Humanitária
Editorial | Segurança e eficácia de antivirais contra SARS-CoV-2 – “Precisamos de evidências, não de otimismo.”
1 Nov, 2021 | 11:02hSafety and efficacy of antivirals against SARS-CoV-2 – The BMJ
Comentário no Twitter
"Effective antivirals have an obvious appeal, but this must not cloud objective and transparent decision making." @dpsg108 and colleagues on the government's stockpiling of molnupiravir and PF-07321332+ritonavir for covid-19https://t.co/JUj1Y9op3P
— The BMJ (@bmj_latest) October 28, 2021
Estudo do CDC | Vacina contra COVID-19 está associada com proteção 5 vezes maior que a “imunidade natural”.
1 Nov, 2021 | 10:59hComentários:
COVID-19 vaccine gives 5 times the protection of ‘natural immunity,’ data show – CIDRAP
COVID shots more protective than past infection, study shows – Associated Press
Comentário no Twitter
⚠️BREAKING—REINFECTION & NATURAL IMMUNITY—new CDC study in hospitalized adults finds: unvaccinated people with prior #COVID19 infection recently were **5 times more likely** to be reinfected / get breakthrough versus people recently fully vaccinated! 🧵 https://t.co/VGmWPmm5lE pic.twitter.com/mlt5fJ3643
— Eric Feigl-Ding (@DrEricDing) October 29, 2021
Opinião | A vacina da Moderna é realmente melhor que a da Pfizer – ou é somente uma dose maior?
1 Nov, 2021 | 10:58hIs Moderna Really Better Than Pfizer—Or Is It Just a Higher Dose? – The Atlantic
Conteúdo relacionado: CDC Report: Moderna’s vaccine associated with greater effectiveness (93%) against Covid-19 hospitalization compared to Pfizer (88%) and J&J (71%) vaccines.
Comentário no Twitter
Nice piece @theatlantic explores question of: Does Moderna give better protection than Pfizer, which gives better protection than J&J (the data would say yes to both)? And – if so – is it simply a matter of the relative doses? https://t.co/Bqav2pNNi7
— Bob Wachter (@Bob_Wachter) October 30, 2021
Estudo sugere que interromper, e não apenas diminuir, o tabagismo está associado com redução no risco de doença cardiovascular.
1 Nov, 2021 | 10:54hSmoking cessation, but not reduction, reduces cardiovascular disease incidence – European Heart Journal (link para o resumo – $ para o texto completo)
Comentário no Twitter
May I just reduce the number of cigarettes? New study shows this is not enough! Smoking cessation, but not reduction, was associated with cardiovascular disease incidence drop.https://t.co/lVgXMwavNs#smoke, #cigarettes, #MI, #cardiotwitter, @ESC_Journals, @escardio. pic.twitter.com/FrqB5V2tx3
— EHJ Editor-in-Chief (@ehj_ed) October 31, 2021
A efetividade da vacina da AstraZeneca em idosos durante a circulação da variante gama do SARS-CoV-2 em São Paulo foi de 77,9% contra Covid-19 sintomática, 87,6% contra internação e 93,6% contra morte.
29 Out, 2021 | 14:59h
Comentário no Twitter (fio – clique para saber mais)
Effectiveness of Oxford-AstraZeneca COVID-19 vaccine by dose in over 60s in São Paulo state, published today in @NatureComms with @juliocroda @otavio_ranzani @datcummings as part of the VEBRA COVID-19 group 1/8https://t.co/zIbPb45nEJ
— Matt Hitchings (@MHitchingsEpi) October 28, 2021
Subnotificação de mortes limita a compreensão sobre o verdadeiro impacto da Covid-19.
29 Out, 2021 | 14:54hUnder-reporting of deaths limits our understanding of true burden of covid-19 – The BMJ
Conteúdos relacionados:
Study shows COVID-19 has caused the biggest decrease in life expectancy since World War II.
Just how do deaths due to COVID-19 stack up?
Exploring the gap between excess mortality and COVID-19 deaths in 67 countries.
COVID-19 has caused 6.9 million deaths globally, more than double what official reports show
Comentário no Twitter
Mortality data have been essential in understanding the spread of covid-19 and navigating the trade-offs that underlie political decision making, yet under-reporting in official death records has greatly obscured this understanding.
What should be done?https://t.co/pI8aVpa3NR
— The BMJ (@bmj_latest) October 14, 2021
Vacinas de mRNA induzem memória imunológica durável contra SARS-CoV-2 e variantes de preocupação.
29 Out, 2021 | 14:53hmRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern – Science
Comentário do autor no Twitter (fio – clique para saber mais)
Antibodies come and go, but memory cells are forever (maybe not forever, but at least 6 months). Our latest in @ScienceMagazine: https://t.co/YHHBMrMsTA
How long does immune memory last after #mRNA vax? Is it effective vs. variants? What about “boosted” responses?
Full 🧵⬇️… pic.twitter.com/oZ5BxLuVdw
— Rishi Goel (@rishirajgoel) October 14, 2021
Nove palavras pandêmicas que poucos acertam como utilizar.
29 Out, 2021 | 14:50hNine Pandemic Words That Almost No One Gets Right – The Atlantic
Diretriz da OMS para o manejo clínico da exposição ao chumbo.
29 Out, 2021 | 14:46hGuideline for clinical management of exposure to lead – World Health Organization
Resumo executivo: Guideline for clinical management of exposure to lead
Ver também: International Lead Poisoning Prevention Week 2021
Comentário no Twitter (fio – clique para saber mais)
It's International Lead Poisoning Prevention Week
Exposure to lead affects human health, especially children's health. There is no safe level of exposure to lead. Even low levels of lead exposure may cause lifelong health problems.
Let's #BanLeadPaint
👉https://t.co/O7NeRcMrW7 pic.twitter.com/mBV13Urf9r
— World Health Organization (WHO) (@WHO) October 24, 2021
Merck autoriza que outros países produzam novo antiviral contra COVID-19.
28 Out, 2021 | 16:17hMerck to allow other nations to produce new COVID-19 antiviral – CIDRAP
Ver também:
Merck will allow drugmakers in other countries to make its COVID-19 pill – NPR
Conteúdos relacionados:
Video: Merck’s Covid pill could transform treatment. Here’s how it works.
How antiviral pill Molnupiravir shot ahead in the COVID drug hunt.
What we know — and don’t know — about Merck’s new Covid-19 pill.
Merck’s Covid-19 pill is great news but may not be a game-changer.
Video | A Pill For COVID? A Doctor Explains Molnupiravir.